Comparing the Long-term Cost-effectiveness of Repaglinide Plus Metformin Versus Nateglinide Plus Metformin in Type 2 Diabetes Patients with Inadequate Glycaemic Control: An Application of the CORE Diabetes Model in Type 2 Diabetes
暂无分享,去创建一个
A. Palmer | G. Spinas | M. Gall | W. Valentine | S. Roze | M. Minshall | M. Lammert | L. Nicklasson